22.418 articles found

Prominent role of alpha3/alpha6beta2* nAChRs in regulating evoked dopamine release in primate putamen: effect of long-term nicotine treatment.

Perez XA, O'Leary KT, Parameswaran N, McIntosh JM, Quik M.

Mol Pharmacol · 2009-01-14

DOI: 10.1124/mol.108.053801PMID: 19144785

METHODS FOR IDENTIFYING SUBSTANCES FOR THE TREATMENT OF ALZHEIMER'S DISEASE

GOOD PAUL F, KOHTZ D. STAVE.

· 2009-01-13

Treatment of Parkinson's disease could be regulated by movement sensors: subcutaneous infusion of varying apomorphine doses according to the intensity of motor activity.

Rodríguez-Molinero A, Pérez-Martínez DA, Català A, Cabestany J, Yuste A.

Med Hypotheses · 2009-01-13

DOI: 10.1016/j.mehy.2008.11.031PMID: 19141365

Quetiapine effective in treatment of inappropriate sexual behavior of lewy body disease with predominant frontal lobe signs.

Prakash R, Pathak A, Munda S, Bagati D.

Am J Alzheimers Dis Other Demen · 2009-01-07

DOI: 10.1177/1533317508329479PMID: 19129547

Induction of adult human bone marrow mesenchymal stromal cells into functional astrocyte-like cells: potential for restorative treatment in Parkinson's disease.

Bahat-Stroomza M, Barhum Y, Levy YS, Karpov O, Bulvik S, Melamed E, Offen D.

J Mol Neurosci · 2009-01-06

DOI: 10.1007/s12031-008-9166-3PMID: 19127447

FLAVONOID AS MEANS FOR THE PROPHYLAXIS AND TREATMENT OF NEURODEGENERATIVE AND OTHER PROTEIN FOLDING-ABERRATION DISEASES

GROSCHUP MARTIN H, EIDEN MARTIN.

· 2009-01-02

Synthetic approaches to novel pyridine and indole derivatives as potential agents for the treatment of neurodegenerative disorders

Colgin N.

· 2009-01-01

Long-term cabergoline therapy is not associated with valvular heart disease in patients with prolactinomas.

Vallette S, Serri K, Rivera J, Santagata P, Delorme S, Garfield N, Kahtani N, Beauregard H, Aris-Jilwan N, Houde G, Serri O.

Pituitary · 2009-01-01

DOI: 10.1007/s11102-008-0134-2PMID: 18594989

Unilateral rubral tremor following treatment with risperidone.

Shen YC.

World J Biol Psychiatry · 2009-01-01

DOI: 10.1080/15622970801958349PMID: 18609423

Levodopa affects functional brain networks in Parkinsonian resting tremor.

Pollok B, Makhloufi H, Butz M, Gross J, Timmermann L, Wojtecki L, Schnitzler A.

Mov Disord · 2009-01-01

DOI: 10.1002/mds.22318PMID: 18823037

Quality of life in early Parkinson's disease treated with levodopa/carbidopa/entacapone.

Fung VS, Herawati L, Wan Y, Movement Disorder Society of Australia Clinical Research and Trials Group, QUEST-AP Study Group.

Mov Disord · 2009-01-01

DOI: 10.1002/mds.21878PMID: 18846551

Physical therapy in Parkinson's disease: evolution and future challenges.

Keus SH, Munneke M, Nijkrake MJ, Kwakkel G, Bloem BR.

Mov Disord · 2009-01-01

DOI: 10.1002/mds.22141PMID: 18946880